VRCA · ISSUER CIK 1660334
Verrica Pharmaceuticals Inc.
Between Jul 31, 2026 and Oct 28, 2026, 4 Verrica Pharmaceuticals Inc. insiders reported $211K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Rieger Jayson (CEO and President, Director), with $126K.
↗4 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$211KInsider buying
$0.00Insider selling
+$211KNet open-market
Aug 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 202617:00 | Aug 17, 2026 | VRCA | Chief Operating Officer | P · Buy | $4.98 | +6,000 | 27,000 | +29% | +$30K | -27.2% | -30.1% |
| Aug 18, 202617:00 | Aug 17, 2026from Aug 14, 2026 | VRCA | CEO and President, Director | P · Buy | $5.03 | +25,000 | 207,593 | +14% | +$126K | -26.5% | -30.8% |
| Aug 18, 202617:00 | Aug 18, 2026from Aug 17, 2026 | VRCA | CMO | P · Buy | $4.91 | +6,230 | 8,587 | +264% | +$31K | -28.2% | -29.2% |
| Aug 18, 202617:00 | Aug 18, 2026 | VRCA | Interim CFO | P · Buy | $4.93 | +5,000 | 23,962 | +26% | +$25K | -27.9% | -29.4% |